Outlook Therapeutics
OTLK
OTLK
64 hedge funds and large institutions have $9.5M invested in Outlook Therapeutics in 2025 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
+1
Holders Change %
+1.59%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
16
Reduced
18
Closed
17
Calls
$31K
Puts
$41K
Net Calls
-$10K
Net Calls Change
-$52K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$663K |
| 2 |
Morgan Stanley
New York
|
+$618K |
| 3 |
Millennium Management
New York
|
+$542K |
| 4 |
Squarepoint
New York
|
+$249K |
| 5 |
Renaissance Technologies
New York
|
+$170K |
Top Sellers
| 1 |
BlackRock
New York
|
-$1.44M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.05M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$488K |
| 4 |
State Street
Boston,
Massachusetts
|
-$324K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$301K |
